You are here


Company Information
SAN FRANCISCO, CA 94107-5418
United States



# of Employees: 8

Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: Yes

Woman Owned: No

Award Charts

Award Listing

  1. Dual Targeted Nanoparticle therapy for Glioblastoma Multiforme

    Amount: $224,980.00

    DESCRIPTION (provided by applicant): Glioblastoma Multiforme is a lethal cancer with devastating prognosis. Glioblastoma affects 5-8 persons per 100,000 population. Even using the most aggressive ther ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  2. Novel physiological depot formulations for long-term butyrylcholinesterase delivery

    Amount: $99,999.00

    Oraganophosphorus poisons are potent nerve agents that function by inhibiting the action of acetylcholinestrase in nerve cells. Of these, G-class nerve agents including: Taubin, Soman and Saurin, and, ...

    SBIRPhase I2013Department of Defense Office for Chemical and Biological Defense
  3. Therapy for Secondary Lymphedema

    Amount: $100,000.00

    Impairment of the lymphatic vascular anatomy and insufficient lymphatic function cause accumulation of interstitial fluid, leading to chronic swelling of the limbs, or lymphedema. In addition to swell ...

    SBIRPhase I2012Department of Defense Army
US Flag An Official Website of the United States Government